Literature DB >> 30527228

Target volume selection and delineation (T and N) for primary radiation treatment of oral cavity, oropharyngeal, hypopharyngeal and laryngeal squamous cell carcinoma.

Vincent Grégoire1, Cai Grau2, Michel Lapeyre3, Philippe Maingon4.   

Abstract

Target volume selection and delineation for both the primary tumor and the lymph nodes are critical steps in the treatment of head and neck tumors with Intensity Modulated Radiation therapy (IMRT). These steps should be based on a probabilistic approach, which is that selection and delineation will be considered as optimal when reaching the best compromise between a too tight volume that could be associated to an unacceptable rate of local recurrence, and a too large volume, which could be associated to an unacceptable rate of treatment morbidity. Failure to do so have been reported to be associated to a higher risk of loco-regional recurrences and/or morbidity after treatment. In this framework, groups of experts proposed sets of guidelines for the radiation oncology community, aiming at standardizing radiotherapy practices of head and neck cancer patients. Although in constant improvement, such guidelines have been shown to translate into more consistent treatment approaches. This review article summarizes the knowledge accumulated over the years on target volume selection and delineation and tries to reconcile the various schools of thoughts on the topic.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Head and neck tumors; IMRT; Neck nodes; Primary tumors; Target volumes

Mesh:

Year:  2018        PMID: 30527228     DOI: 10.1016/j.oraloncology.2018.10.034

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  12 in total

Review 1.  Standardization for oncologic head and neck surgery.

Authors:  Ohad Ronen; K Thomas Robbins; Remco de Bree; Orlando Guntinas-Lichius; Dana M Hartl; Akihiro Homma; Avi Khafif; Luiz P Kowalski; Fernando López; Antti A Mäkitie; Wai Tong Ng; Alessandra Rinaldo; Juan P Rodrigo; Alvaro Sanabria; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-05-12       Impact factor: 2.503

2.  LncRNA MALAT1 inhibits the proliferation and invasiveness of laryngeal squamous cell carcinoma Hep-2 cells by modulating miR-362-3p.

Authors:  Baotong Xie; Zhaohua Wang; Tao Li; Junfang Xue; Chunming Zhang
Journal:  Am J Transl Res       Date:  2022-06-15       Impact factor: 3.940

3.  Impact of dosimetric factors on long-term percutaneous enteral gastrostomy (PEG) tube dependence in head and neck cancer patients after (chemo)radiotherapy-results from a prospective randomized trial.

Authors:  Anastassia Löser; Maximilian Grohmann; Anna Finger; Franziska Greinert; Linda Krause; Isabel Molwitz; Andreas Krüll; Cordula Petersen
Journal:  Strahlenther Onkol       Date:  2022-08-25       Impact factor: 4.033

4.  Low risk of contralateral lymph node recurrence in lateralized head and neck carcinoma after postoperative ipsilateral radiotherapy.

Authors:  Mirja M Wirtz; Susanne Temming; Martin Kocher; Sabine Kunze; Robert Semrau
Journal:  Strahlenther Onkol       Date:  2019-12-12       Impact factor: 3.621

5.  Radiotherapy Increases the Incidence of Herpes Zoster in Oral Cavity Cancer Patients - a National Population-based Cohort Study.

Authors:  Yung-Shuo Kao; Yen Hsu; Chung Y Hsu
Journal:  In Vivo       Date:  2021 Nov-Dec       Impact factor: 2.155

6.  N6-methyladenosine modification of circCUX1 confers radioresistance of hypopharyngeal squamous cell carcinoma through caspase1 pathway.

Authors:  Ping Wu; Xing Fang; Yalan Liu; Yaoyun Tang; Wei Wang; Xin Li; Yuhua Fan
Journal:  Cell Death Dis       Date:  2021-03-19       Impact factor: 8.469

7.  Feasibility of DW-MRI analysis of salivary glands during head and neck radiotherapy.

Authors:  Aileen Duffton; Olivia Kemp; Lynsey Devlin; Lisa Hay; Philip McLoone; Claire Paterson
Journal:  Tech Innov Patient Support Radiat Oncol       Date:  2021-09-04

8.  Adaptive dose escalated radiotherapy in oropharyngeal cancers: a treatment planning feasibility study.

Authors:  Laura Grocutt; Claire Paterson; Ronan M Valentine
Journal:  Radiat Oncol       Date:  2022-02-05       Impact factor: 3.481

9.  Analysis of dose using CBCT and synthetic CT during head and neck radiotherapy: A single centre feasibility study.

Authors:  Lisa K Hay; Claire Paterson; Philip McLoone; Eliane Miguel-Chumacero; Ronan Valentine; Suzanne Currie; Derek Grose; Stefano Schipani; Christina Wilson; Ioanna Nixon; Allan James; Aileen Duffton
Journal:  Tech Innov Patient Support Radiat Oncol       Date:  2020-03-23

10.  The impact of nutritional counseling on thyroid disorders in head and neck cancer patients after (chemo)radiotherapy: results from a prospective interventional trial.

Authors:  Anastassia Löser; Kerstin Ramke; Maximilian Grohmann; Linda Krause; Pia Roser; Franziska Greinert; Anna Finger; Margaret Sommer; Eva Culmann; Tessa Lorenz; Saskia Becker; Marvin Henze; Daniel Schodrok; Julia von Grundherr; Silke Tribius; Andreas Krüll; Cordula Petersen
Journal:  Strahlenther Onkol       Date:  2021-11-01       Impact factor: 3.621

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.